China Unconditionally Approves Kimberly-Clark’s Acquisition Of Kenvue On October 10, 2026, Clearing Key Antitrust Hurdle

On October 10, 2026, China's regulatory authority granted unconditional approval for Kimberly-Clark's acquisition of Kenvue, overcoming a significant antitrust hurdle. This approval is expected to facilitate Kimberly-Clark's strategic expansion in the consumer health sector. The acquisition is likely to impact Kimberly-Clark's market position and financial performance positively.